Genentech/Xoma Raptiva Promotions Likely To Focus On Dosing Convenience

Genentech/Xoma plan to differentiate the psoriasis agent Raptiva from other biologics by highlighting Raptiva's dosing convenience

More from Archive

More from Pink Sheet